Home Cart Sign in  
Chemical Structure| 754240-09-0 Chemical Structure| 754240-09-0

Structure of EHT 1864
CAS No.: 754240-09-0

Chemical Structure| 754240-09-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

EHT 1864 2HCl is an inhibitor of Rac1 (Kd = 40 nM), Rac1b (Kd = 50 nM), Rac2 (Kd = 60 nM) and Rac3 (Kd = 250 nM).

Synonyms: EHT 1864 2HCl

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of EHT 1864

CAS No. :754240-09-0
Formula : C25H29Cl2F3N2O4S
M.W : 581.48
SMILES Code : O=C1C=C(CN2CCOCC2)OC=C1OCCCCCSC3=CC=NC4=CC(C(F)(F)F)=CC=C34.[H]Cl.[H]Cl
Synonyms :
EHT 1864 2HCl
MDL No. :MFCD11114384
InChI Key :LSECOAJFCKFQJG-UHFFFAOYSA-N
Pubchem ID :9938202

Safety of EHT 1864

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of EHT 1864

GPCR

Isoform Comparison

Biological Activity

Target
  • Rac

    Rac3, Kd:50 nM

    Rac1, Kd:40 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
Platelets 100 µM 10 minutes Inhibition of Rac1 activation, reduced α-granule and dense granule release Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):434-41.
Thymic endothelial cells (exECs) 50 µM 20 hours To investigate the effect of Rac1 GTPase inhibition on Bmp4 expression. Results showed that Rac1 inhibition significantly increased Bmp4 expression. Cell Rep. 2021 Oct 5;37(1):109789.
Dendritic cells (DCs) 50 µM 20 hours To investigate the effect of Rac1 GTPase inhibition on Il12p40 expression. Results showed that Rac1 inhibition significantly increased Il12p40 expression. Cell Rep. 2021 Oct 5;37(1):109789.
INS-1 832/13 cells 10 µM 24 hours Inhibition of HG-induced p53 activation, suggesting that Rac1 activation is requisite for HG-induced activation of p53 in INS-1 832/13 cells. Apoptosis. 2017 May;22(5):597-607.
Rat islets 10 µM 24 hours Inhibition of HG-induced p53 phosphorylation, indicating the regulatory role of Rac1 in p53 activation. Apoptosis. 2017 May;22(5):597-607.
WPMY-1 cells 25 µM 24 hours To assess the effect of EHT 1864 on the survival of WPMY-1 cells, results showed 81% cell survival after 24 hours. Br J Pharmacol. 2015 Jun;172(11):2905-17.
WPMY-1 cells 100 µM 24 hours To assess the effect of EHT 1864 on the survival of WPMY-1 cells, results showed 64% cell survival after 24 hours. Br J Pharmacol. 2015 Jun;172(11):2905-17.
INS-1 832/13 cells 10 µM 24 hours Inhibits HG-induced p38MAPK activation, suggesting a regulatory role for Rac1 in the cascade of events leading to HG-induced p38MAPK activation. Biochem Pharmacol. 2015 Jun 15;95(4):301-10.
Human microvascular endothelial cells 1 µM 30 minutes EHT1864 did not interfere with Ang II and ET-1-induced NADPH oxidase activation, but decreased Ang II and ET-1-stimulated Rac-1 translocation, as evidenced by decreased membrane expression of Rac-1. Circ Res. 2010 Apr 30;106(8):1363-73.
MCF-7 cells 2 µM, 5 µM, 10 µM 5 days EHT 1864 was more effective than 4-hydroxytamoxifen (OHT) in blocking E2-stimulated MCF-7 cell growth; 5 or 10 μM EHT 1864 prevented all E2-stimulated cell growth Oncogene. 2021 Oct;40(40):5950-5962.
S100β-v-erbB/p53−/− glioma stem-like cells 1 µM 7 days EHT-1864 significantly inhibited VEGF secretion, decreased stem cell self-renewal, and inhibited tumor growth. Oncogene. 2018 Feb 22;37(8):1107-1118.
A431 cells 25 µM Inhibition of Rac activity to rescue the enhanced migration ability in DP knockdown cells J Invest Dermatol. 2019 Jun;139(6):1227-1236.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice C57BL/6 WT or Nod2−/− mice Intraperitoneal injection 40 mg/kg Injected on days 3, 5, and 7, continued until day 14 To investigate the effect of Rac1 GTPase inhibition on thymic regeneration and peripheral T cell recovery. Results showed that EHT1864 significantly increased thymic cellularity and promoted the recovery of peripheral CD4+ naive T cells. Cell Rep. 2021 Oct 5;37(1):109789.
BALB/c mice Subchronic mouse lung tissue damage model Intraperitoneal injection 5 mg/kg Three times per week for six weeks EHT1864 attenuated the IR-induced increase in breathing frequency and reduced the percentage of γH2AX and 53BP1-positive cells. This indicates that inhibition of Rac1 signaling lowers IR-induced residual DNA damage by promoting DNA repair. Moreover, EHT1864 protected lung tissue from IR-triggered apoptosis and mitigated the IR-stimulated increase in regenerative proliferation. Cell Death Dis. 2017 Aug 10;8(8):e2978
Mice S100β-v-erbB/p53−/− tumor allograft model Intraperitoneal injection 80 mg/kg Once a day for 10 days EHT-1864 significantly reduced VEGF secretion, slowed tumor growth, and increased the survival of mice allografted with S100β-v-erbB/p53?/? glioma stem-like cells. Oncogene. 2018 Feb 22;37(8):1107-1118.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.72mL

0.34mL

0.17mL

8.60mL

1.72mL

0.86mL

17.20mL

3.44mL

1.72mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.

References

 

Historical Records

Categories